Zobrazeno 1 - 8 of 8 pro vyhledávání: '"Liza O'Dowd"'
3
Cloud-based data systems in drug regulation: an industry perspective
Autor: Max Wegner, Helen Fitton, Robert Kowalski, Peter Honig, Michelle Rohrer, Khyati Roberts, Roopal Thakkar, Mathias Hukkelhoven, Mark Taisey, Hilary Malone, Stacy Holdsworth, Andrew S. Robertson, Sandra Milligan, Carlos Garner, Liza O’Dowd, Jerry Stewart, Karin Van Baelen, Fabio Bisordi
Publikováno v: Nature Reviews Drug Discovery. 19:365-366
Cloud-based systems for data submitted by sponsors to drug regulatory agencies have the potential to accelerate drug development, streamline regulatory review and enhance regulatory decision-making. Here, we provide a vision for integrating cloud-ena
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a6eca4e9f9078172d4ade4d94780b51c
https://doi.org/10.1038/d41573-019-00193-7
Zobrazit plný text záznamu
4
Efficacy and safety of budesonide/formoterol pressurized metered-dose inhaler: randomized controlled trial comparing once- and twice-daily dosing in patients with asthma
Autor: William E, Berger, Eugene R, Bleecker, Liza, O'Dowd, Christopher J, Miller, William, Mezzanotte
Publikováno v: Allergy and asthma proceedings. 31(1)
Asthma guidelines recommend titrating maintenance medications to the lowest effective dose. This study assessed the efficacy and tolerability of reducing the frequency of dosing in patients previously controlled with twice-daily budesonide/formoterol
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::030c161f6f356b09af73a2130ff77104
https://pubmed.ncbi.nlm.nih.gov/20167145
Zobrazit plný text záznamu
5
The safety and clinical benefit of budesonide/formoterol pressurized metered-dose inhaler versus budesonide alone in children
Autor: William E, Berger, Jeffrey G, Leflein, David E, Geller, Bhash, Parasuraman, Christopher J, Miller, Christopher D, O'Brien, Liza, O'Dowd
Publikováno v: Allergy and asthma proceedings. 31(1)
Few studies have evaluated inhaled corticosteroid (ICS)/long-acting beta(2)-adrenergic agonist combination therapy in asthmatic children. This study was designed to evaluate the safety (primary) and clinical benefits (secondary) of budesonide/formote
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::7f3aed9e8d305d9a319e4673011b7e27
https://pubmed.ncbi.nlm.nih.gov/20167143
Zobrazit plný text záznamu
6
Quantifying asthma patient preferences for onset of effect of combination inhaled corticosteroids and long-acting beta2-agonist maintenance medications
Autor: A. Brett Hauber, Liza O'dowd, David Meddis, Ateesha F. Mohamed, F. Reed Johnson, Samuel Wagner
Publikováno v: Allergy and asthma proceedings. 30(2)
The Onset-of-Effect Questionnaire (OEQ) is a self-administered instrument used to assess patient perception of how quickly asthma maintenance medications begin to work. This study was designed to quantify the relative importance that patients using c
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::198d930383f30a12e5a49c10708cccc6
https://pubmed.ncbi.nlm.nih.gov/19463204
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje